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SUMMARY. The NS1 protein of influenza A viruses is known as a nonessential virulence factor inhibiting type I interferon
(IFN) production in mammals and in chicken cells. Whether NS1 inhibits the induction of type I IFNs in duck cells is currently
unknown. In order to investigate this issue, we used reverse genetics to generate a virus expressing a truncated NS1 protein. Using
the low pathogenic avian influenza virus A/turkey/Italy/977/1999 (H7N1) as a backbone, we were able to rescue a virus expressing
a truncated NS1 protein of 99 amino acids in length. The truncated virus replicated poorly in duck embryonic fibroblasts, but
reached high titers in the mammalian IFN-deficient Vero cell line. Using a gene reporter system to measure duck type I IFN
production, we showed that the truncated virus is a potent inducer of type I IFN in cell culture. These results show that the NS1
protein functions to prevent the induction of IFN in duck cells and underline the need for a functional NS1 protein in order for the
virus to express its full virulence.
RESUMEN. Nota de Investigacio´n—El truncamiento de la proteı´na NS1 convierte a un virus de la influenza aviar de baja
patogenicidad en un potente inductor de interfero´n en ce´lulas de pato.
La proteı´na NS1 de virus de la influenza A es reconocida como un factor de virulencia no esencial que inhibe la produccio´n de
interfero´n tipo I en ce´lulas de mamı´feros y de pollos. Actualmente, se desconoce si la proteı´na NS1 inhibe la induccio´n de
interfero´n tipo I en ce´lulas de pato. Para investigar esta interrogante, se utilizo´ la gene´tica reversa para generar un virus que
expresaba la proteı´na NS1 truncada. Mediante la utilizacio´n del virus de la influenza aviar de baja patogenicidad A/Pavo/Italia/977/
1999 (H7N1) como base, se pudo rescatar un virus que expresaba la proteı´na NS1 truncada que tenı´a una extensio´n de 99
aminoa´cidos. El virus truncado se replico´ de manera inadecuada en fibroblastos de embriones de pato, pero alcanzo´ tı´tulos altos en
la lı´nea celular de ce´lulas de mamı´fero Vero que era deficiente en interfero´n. Utilizando un sistema indicador de genes para medir la
produccio´n de interfero´n tipo I de pato, se demostro´ que el virus truncado es un potente inductor de interfero´n en los cultivos
celulares. Estos resultados muestran que la proteı´na NS1 funciona previniendo la induccio´n de interfero´n en ce´lulas de pato y
subraya la necesidad de una proteı´na NS1 funcional para que el virus exprese su virulencia completa.
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Abbreviations: aa5 amino acid(s); DEF5 duck embryonic fibroblasts; DMEM5Dulbecco’s modified Eagle’s medium;
GAPDH5 glyceraldehyde-3-phosphate dehydrogenase; HEK5 human embryonic kidney; hpi5 hours post-infection; IFN5
interferon; IU5 international unit; LPAI5 low pathogenic influenza virus; m.o.i.5multiplicity of infection; NEP5 nuclear
export protein; n.i.5 not infected; NP5 nucleoprotein; NS5 non-structural; NS15 non-structural protein 1; p.f.u.5 plaque
forming unit; RT-PCR5 reverse transcription–polymerase chain reaction; SDS-PAGE5 sodium dodecyl sulfate polyacrylamide
gel electrophoresis; TPCK5 L-1-tosylamido-2-phenylethyl chloromethyl ketone; wt5wild-type
Influenza viruses are the causative agents of epizootics and a
potential source of zoonosis. Although the recent outbreaks of highly
pathogenic H5N1 virus have created a great deal of interest about
the virulence factors in mammals, little is known about the
interaction between influenza viruses and their natural reservoir,
namely waterfowl (12). In particular, the extent of the innate
immune response and its consequences on the kinetics of infection
in ducks are unknown.
In mammals, influenza nonstructural protein 1 (NS1) is described
as a nonessential virulence factor, able to inhibit the innate antiviral
immune response of infected cells. This is mainly achieved through
the interaction of the NS1 effector domain with several cellular
proteins. This effector domain has been mapped to amino acids 73
to 230, which correspond to the C-terminal region of the protein
(6). In ducks, the interaction between NS1 and the innate immune
response remains to be evaluated.
Using reverse genetics, NS1-truncated viruses have been generated
and their phenotype studied in several species including mouse (5),
horse (13), pig (17), and macaque (1). These viruses proved to be
attenuated and were strong interferon (IFN) inducers, underlining
the role of NS1 as an antagonist of the innate immune response.
NS1 also acts as a virulence factor inhibiting IFN production in
chicken cells, as evidenced by studies using a natural low pathogenic
influenza virus (LPAI) with a truncated NS1 protein, or an H7N7
influenza virus with a truncated NS1 generated by reverse genetics
(3,10,11). At present, the consequences of NS1 truncation on
infection of ducks remain unknown.
To answer this question, we used the LPAI virus A/turkey/Italy/
977/1999(H7N1) as a backbone to generate, by reverse genetics, an
LPAI virus expressing a truncated NS1 protein, of 99 amino acids
(aa) in length, named H7N1 1–99. Compared with the wild-type
(wt) virus, the mutant replicated poorly in primary duck embryonic
fibroblasts (DEF), but reached high titers in the IFN-deficient Vero
cell line. The mutant virus appeared as a very potent type I IFNACorresponding author: r.volmer@envt.fr
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inducer compared with the wt virus when infecting duck cells. This
study illustrates the importance of the NS1 protein as an antagonist
of the host innate immune response in ducks.
MATERIALS AND METHODS
Cells, viruses, and antibodies. DEF were obtained from 10-day-old
Pekin duck (Anas platyrhynchos domestica) embryos. All cells, including
human embryonic kidney (HEK) 293T (American Type Culture
Collection, Manassas, VA) and Vero cells (American Type Culture
Collection) were grown in Dulbecco’s modified eagle’s medium
(DMEM) supplemented with penicillin (104 U/ml), streptomycin
(10 mg/ml), and 10% fetal bovine serum at 37 C. The following
antibodies were used: polyclonal rabbit serum directed against NS1
(kindly provided by Dr. D. Marc [INRA, Tours, France]), polyclonal
rabbit anti-nucleoprotein (NP; kindly provided by Dr. G. Whittaker
[Cornell University, Ithaca, NY]), mouse monoclonal antibody directed
against NP (Argene, Verniolle, France), and mouse monoclonal
antibody directed against glyceraldehyde-3-phosphate dehydrogenase
(GAPDH; Chemicon, Millipore, Billerica, MA). The LPAI virus A/
turkey/Italy/977/1999 (H7N1) was a kind gift of Dr. I. Capua (Istituto
Zooprofilattico Sperimentale Delle Venezie, Legnaro, Italy).
Viruses and reverse genetics. Viral genome was extracted from the
allantoic fluid of chicken embryonated eggs infected with the LPAI A/
turkey/Italy/977/1999 (H7N1) virus (third egg passage) using the
QIAamp Viral RNA mini kit (Qiagen, Valencia, CA) following the
manufacturer’s protocol. The eight viral segments were subsequently
reverse-transcribed using the Superscript II enzyme (Invitrogen, Carlsbad,
CA) and Uni 12 as a universal primer for viral genome segments (8).
Using specific primers for each segment described by Hofmann et al. (8),
the viral genome was amplified with the Phusion high fidelity polymerase
(Finnzymes, Espoo, Finland). Each segment was then cloned into a shuttle
plasmid (Strataclone blunt PCR cloning kit, Stratagene). After sequenc-
ing, plasmids containing segments identical to the published sequences of
A/turkey/Italy/977/1999 (H7N1) were used to clone each of the viral
segments into the pHW2000 vector, kindly provided by Prof. Webster
(St. Jude Children Research Hospital, Memphis, TN) (7). In order to
generate a mutant virus, site-directed mutagenesis was performed on the
NS segment using the QuickChange II kit (Stratagene, La Jolla, CA)
following the manufacturer’s protocol. The introduced mutation is
presented in Fig. 1. The plasmid was then sequenced to ensure the
absence of unwanted mutations.
Rescue of infectious viruses. HEK 293T cells were transfected with
0.3 mg of each of the eight plasmids corresponding to the viral segments,
using the lipophilic transfection reagent LTX (Invitrogen) with Plus
reagent (Invitrogen), as described in the manufacturer’s protocol. To
avoid multicycle replication in HEK 293T, no trypsin was added to the
culture medium at this step. Three wells were transfected for each rescue
and were respectively scraped at 24, 36, and 48 hours posttransfection.
Scraped cells and culture medium were then transferred on DEF grown
in OptiMEM supplemented with L-1-tosylamido-2-phenylethyl chlor-
omethyl ketone (TPCK) trypsin (2 mg/ml; Thermo Scientific, Rockford,
IL) to increase viral titer. In order to produce viral stock, H7N1 wt was
further inoculated to embryonated eggs, whereas H7N1 1–99 was used
to infect Vero cells. Viral titers were measured by plaque assay on Vero
cells. We verified the identity of amplified viruses by sequencing
amplicons of each viral gene segment using reverse transcription–
polymerase chain reaction (RT-PCR).
Infections. All infections were performed in DMEM supplemented
with 0.2% bovine serum albumin, and TPCK trypsin (2 mg/ml) was
added in the case of multicycle growth analysis.
Hemagglutination assay. Cell culture supernatants were harvested,
serially diluted in phosphate-buffered saline, and assayed for hemagglu-
tination of 1% horse red blood cells in V-bottom, 96-well plates by
adapting a described protocol (9).
Western blotting. DEF infected, or not (n.i.), with either H7N1 wt
or H7N1 1–99, were lysed 4, 8, and 20 hours postinfection (hpi) in
Ipegal buffer in the presence of protease inhibitors (Roche Diagnostics,
Meylan, France). Cell lysates were treated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE), followed by Western
blotting. Polyvinylidene fluoride membranes were incubated with rabbit
anti-NS1 polyclonal serum (1/10,000), a rabbit anti-NP polyclonal
serum (1/5,000), and mouse anti-GAPDH (1/20,000). Horseradish
peroxidase-conjugated relevant antibodies were added and revelation was
done using the Supersignal West Dura kit (Thermo Scientific).
Titration of type I IFNs by reporter assay. Recombinant duck IFN-
a was produced by transfecting (monkey) COS cells with a plasmid
encoding IFN-a, kindly provided by Dr. U. Schultz (Universita¨t
Freiburg, Germany) (15). Supernatant was harvested and titration
done on DEF by measuring protection against vesicular stomatitis
virus-induced cytopathic effect. The titer reached 12,000 IU/ml. To
determine the amount of type I IFNs produced in the supernatant of
infected cells, a reporter assay was used. DEF were cotransfected by
electroporation (BioRad GenePulser X cell; Biorad, Marnee-la-
Coquette, France) with a plasmid containing the sequence of firefly
luciferase under the control of chicken Mx promoter, MxLuc, kindly
provided by P. Staeheli (Universita¨t Freiburg, Germany), and a
plasmid containing the sequence of Renilla luciferase under the control
of herpes simplex virus TK promoter (Promega) (16). Sixteen hours
after transfection, cells were stimulated with supernatant from cells
infected with an m.o.i. of 2 (virus in the supernatant was inactivated
by acid treatment at pH 5 2), or recombinant duck IFN-a, for 16 hr.
The activity of firefly luciferase was then measured on a Tecan Infinite
Fig. 1. Production of a mutated virus expressing a 99-aa truncated NS1 Protein. Schematic of H7N1 wt and H7N1 1–99 NS segment.
Influenza A NS segment encodes two proteins, NS1 and NEP, which are represented. NEP is obtained by the splicing of NS1 mRNA. Wild-type
NS1 is 230 aa long. The mutation performed on the NS segment occurs within the intronic region of the NEP open reading frame and, therefore,
only affects NS1, resulting in a truncation after position 99.
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200 96 plate reader (Tecan, Ma¨nnedorf, Switzerland) using the Dual-
Glo Luciferase assay system (Promega, Madison, WI) and was
normalized by the Renilla activity.
RESULTS
Production of a mutant virus expressing a truncated NS1
protein by reverse genetics. We mutated the NS segment in order
to produce a 99-aa truncated NS1 protein, following a strategy
successfully used by others (10,13,17,18). The mutation occurs in
the intronic region of the nuclear export protein (NEP) so that the
modification alters only NS1. Deleting this large portion of the
protein allows the conservation of some functions of the NS1
protein carried on its N-terminal region, such as double-stranded
RNA binding (Fig. 1) (6). Plasmid-based rescue was performed on
the highly transfectable HEK 293T cell line to allow vector
expression: Infectious virus produced by transfected cells was then
amplified on DEF in the presence of trypsin to allow multicycle
growth. DEF supernatant reached a titer of 2.5 3 105 plaque-
forming units (p.f.u.) per ml in the case of H7N1 wt, whereas H7N1
1–99 replicated poorly, with a titer of 103 p.f.u./ml. The reduced
titer of H7N1 1–99 could be due to the IFN response of DEF.
Therefore, we decided to further amplify the mutant virus on the
IFN-deficient cell line Vero. H7N1wt was amplified on embryo-
nated eggs. By these means, H7N1 wt reached 3.3 3 107 p.f.u./ml
and H7N1 1–99 titrated at 107 p.f.u./ml.
We checked the viability of the mutant virus by infecting DEF at
an m.o.i. of two. The expression of NP and NS1 proteins was then
analyzed by Western blot (Fig. 2). The level of NP expression
appeared similar for both viruses at 4 hpi, 8 hpi, and 20 hpi. NS1
protein was detected specifically in H7N1 wt infected cells as a band
migrating just below the 28 kDa marker, corresponding to full-
length NS1. A longer exposure time resulted in background signal,
present in both infected and control cells. However, a weak band
appeared at approximately 13 kDa, specifically in the case of H7N1
1–99 infected cell lysate (Fig. 2, arrow); this band most likely
corresponded to NS1, as its size matched the theoretical molecular
weight of the truncated protein. These data illustrate the
effectiveness of the mutation carried out on the viral genome.
Collectively, these results show that the mutant virus expressing a
truncated NS1 protein is able to infect DEF and to replicate in these
cells.
H7N1 1–99 replicates poorly in DEF but reaches high titers in
Vero cells. To investigate the replicative capacity of the mutant
virus, infections were performed in DEF and Vero cells at an m.o.i.
of 0.01, and HA titer of the supernatant was measured at different
time-points (Fig. 3). In DEF, the wt virus reached an HA titer of 64
within 24 hr and maintained this titer until the end of the
experiment. In contrast, the titer of the mutant virus peaked at 32
HA units and then decreased to 16. In Vero cells, both viruses
reached a high titer (1024 HA units) by 72 hr. These data show, in
agreement with the findings from other groups, that the replicative
capacity of the mutant virus is altered in IFN-competent cells such as
DEF, but is similar to wt virus in the IFN-deficient Vero cell line
(5,10).
Truncation of the NS1 protein converts LPAI into a strong
IFN inducer in DEF. In previous works, several groups have shown
that viruses expressing a truncated NS1 elicited a major type I IFN
response in infected cells compared to their wild-type counterparts
(1,5,10,11,13,17). In order to check for the consequences of our
Fig. 2. Replication of H7N1 1–99 in vitro. Western blots for NP, GAPDH, and NS1: DEF were infected or not (n.i.) with wt or mutant virus
and lysed respectively at 4, 8, and 20 hpi. Cell lysates were analyzed by SDS-PAGE, followed by Western blot analysis for NP (upper), GAPDH
(middle), and NS1 (lower panel). In the case of NS1, a longer exposure time (lower panel) allowed us to visualize a band corresponding to the
truncated protein (arrow).
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mutation in duck cells, we used a reporter assay to measure type I
IFN production of infected DEF. Stimulating DEF with recombi-
nant duck IFN-a resulted in a detectable signal for a 5 IU/ml
concentration (Fig. 4). The response appeared linear up to a
concentration of 500 IU/ml. Supernatant from wt virus infected
cells harvested 20 hpi contained a concentration of type I IFNs of
about 50 IU/ml. In contrast, supernatant from mutant virus-
infected cells resulted in a very strong response in our assay,
corresponding to a concentration much higher than 500 IU/ml.
These data show that truncating the NS1 protein converts an LPAI
virus into a strong type I IFNs inducer in duck cells.
DISCUSSION
By using reverse genetics, we were able to create a mutant avian
influenza virus expressing a truncated NS1 protein. The mutant
virus displayed an impaired replication in DEF and induced high
titers of type I IFNs. This shows that NS1 inhibits IFN production
in duck cells, as in chicken and mammalian cells. The reduced
growth of the H7N1 1–99 virus during multi-cycle analyses in DEF
is most likely due to the synthesis of IFN-induced antiviral effectors.
At present, the nature of these effectors in duck cells remains
unknown. Surprisingly, Mx protein, which is a potent IFN-induced
antiviral protein in mammals, appears to be inactive in ducks (2).
Previous studies have shown that LPAI viruses with a truncated
NS1 were attenuated in chickens (3,20). Although LPAI are
nonpathogenic in ducks, it would be interesting to evaluate the
impact of NS1 truncation on the tissue tropism and on the duration
of infection (12). In addition, the H7N1 1–99 is a strong IFN inducer
and, thus, represents an interesting means to study the innate immune
response during influenza virus infection of ducks, a phenomenon
poorly described in this species. A particularly efficient innate immune
response may explain why ducks survive infections with highly
pathogenic influenza viruses that are lethal to other avian species (19).
Finally, viruses expressing a truncated NS1 proved to be both attenuated
and immunogenic when administered to mammals and chickens and,
therefore, are promising attenuated vaccine strains (1,4,14,18,20). The
potential of theH7N1 1–99 virus as a vaccine strain could be the subject
of further studies in ducks and other avian species.
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